A fast-growing, Birmingham-based, Black-owned health care startup is partnering with one of the world’s most influential health research and pharmaceutical companies to help boost the participation of African Americans in oncology clinical studies.
Birmingham-based Acclinate is a digital health company focused on improving health equity through predictive analytics technology and community engagement. It recently announced a collaboration with Merck, known as MSD outside the United States and Canada, to help increase Black community participation in Merck’s oncology clinical studies.
“We’re proud to be working with Merck because being a champion for health equity through inclusive research takes strategic orientation and proactiveness. We look forward to seeing how our continued collaboration can positively impact patients,” said Del Smith, Acclinate CEO and co-founder.
As part of the collaboration, Acclinate will deploy its Nowincluded platform. Nowincluded offers access…
…
Continue reading this article at; www.alabamanewscenter.com
Author : Alabama News Center Staff
Alabama News Center
https://www.alabamanewscenter.com/2023/12/12/alabama-based-acclinate-collaborates-with-merck-to-expand-diversity-in-clinical-trials/
Innovation,Acclinate,Alabama,Alabama Department of Commerce,Alabama Regional Medical Services,Birmingham,Del Smith,Denham Building,Federal TechHubs,Greg Canfield,healthcare,healthcare startups,Huntsville,Merck,Parkside,Savvy,TechHub,Tiffany Whitlow,Trialbee
#Alabamabased #Acclinate #collaborates #Merck #expand #diversity #i..
[gs-fb-comments]